The Latest Cardiac and Vascular News
— Visirna Therapeutics, the Joint Venture formed by Arrowhead and Vivo, received an exclusive license in Greater China to four of Arrowhead’s RNAi-based investigational cardiometabolic medicines — Vivo provided an initial investment of $60 million into Visirna — Arrowhead and Vivo both received equity ownership of Visirna, with Arrowhead being […]
LONDON–(BUSINESS WIRE)–Silence Therapeutics plc (Nasdaq: SLN), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced that it will receive a $2.0 million cash payment from Hansoh Pharmaceutical Group Company Limited (“Hansoh”) […]
ANDOVER, Mass., April 21, 2022 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on April 18, 2022, TransMedics granted non-qualified stock options to purchase an aggregate of 29,800 shares of its common stock […]
LAGUNA HILLS, Calif. and SHANGHAI and BOCHUM, Germany, April 21, 2022 /PRNewswire/ — Wallaby Medical (“Wallaby” or the “Company”), a global innovative medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke, today announced that it has acquired phenox GmbH, including phenox’s femtos GmbH (“femtos”), (together “phenox”), a German-based global innovation and technology […]
SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, is proud to announce that Brian G. Lloyd, Merit’s Chief Legal Officer and Corporate Secretary, is a recipient of Utah Business Magazine’s Corporate Counsel Award. The award recognizes exceptional […]
CALGARY, AB and SAN FRANCISCO, April 20, 2022 /PRNewswire/ — Thoma Bravo, a leading software investment firm, today announced the completion of its strategic growth investment in Circle Cardiovascular Imaging Inc. (“Circle CVI”), the global leader in cardiovascular imaging solutions. Circle CVI is the leading provider of AI-based cardiac imaging and reporting solutions, including […]
ARTARMON, Australia, April 20, 2022 /PRNewswire/ — Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced neural activation and sensing technologies designed to treat debilitating neurological disorders, today announced the appointment of Robert (Bob) Palmisano to its Board of […]
Sales growth of 13.8 percent; organic sales growth of 17.5 percent Global COVID-19 testing-related sales of $3.3 billion in the first quarter Excluding COVID-19 testing-related sales, first-quarter reported sales growth of 3.9 percent and organic sales growth of 7.7 percent GAAP diluted EPS growth of 37.0 percent; adjusted diluted EPS growth of […]
Company advances its next-generation thrombectomy device CAMPBELL, Calif., April 19, 2022 /PRNewswire/ — Akura Medical, Inc., a Shifamed portfolio company, announced today that seasoned medtech executive, Murali Srivathsa, has joined as President and CEO. With over two decades of industry experience, Murali brings a wealth of medical device and senior leadership expertise. He joins as […]
MORRISVILLE, N.C., April 18, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) today announced the closing of its previously announced underwritten public offering of 11,274,510 shares of its common stock, which includes full exercise of the underwriters’ over-allotment option to purchase 1,470,588 additional shares of common stock, at a […]
